New approach methodologies to model liver fibrosis in metabolic dysfunction-associated steatohepatitis
{{output}}
Metabolic dysfunction-associated steatohepatitis (MASH) is a significant global health issue and a leading cause of liver fibrosis, with no effective pharmacological treatments available. Conventional 2D cell cultures and animal models do not fully recapitulat... ...
